Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems vice president Alistair N. Sporck reported a routine tax-related share withholding tied to equity compensation. On January 27, 2026, 152 shares of common stock were withheld at $27.75 per share to satisfy tax obligations upon vesting of restricted stock units, which is not an open market sale.
After this transaction, Sporck beneficially owned 28,153 shares of Aehr Test Systems common stock directly, including shares subject to unvested restricted stock units, and 5,214 shares indirectly through a trust.
Aehr Test Systems executive Vernon Rogers reported a small tax-related share withholding. On January 27, 2026, 160 shares of common stock were withheld at
This transaction is coded "F," indicating a tax withholding rather than an open-market sale, and the disclosure states it does not represent a sale by the reporting person. After this event, Rogers beneficially owned 177,206 shares of Aehr Test Systems common stock, which includes shares underlying unvested restricted stock units.
AEHR Test Systems CTO Donald P. Richmond II reported an automatic share withholding related to equity compensation. On 01/27/2026, 117 shares of common stock were withheld at
Aehr Test Systems President and CEO Erickson Gayn, also a director, reported an automatic share withholding related to equity compensation. On January 27, 2026, 820 shares of common stock were withheld at
After this transaction, Gayn beneficially owned 251,299 shares of common stock directly. He also reported an additional 291,628 shares held indirectly through a trust, which includes shares subject to unvested restricted stock units and unvested restricted shares.
AEHR TEST SYSTEMS Chief Operating Officer ENGINEER ADIL reported an automatic share withholding related to equity compensation. On 01/27/2026, 163 shares of common stock were withheld at $27.75 per share to cover tax obligations upon vesting of restricted stock units, which the company notes does not represent a sale. After this transaction, ADIL beneficially owned 45,676 common shares, including shares subject to unvested restricted stock units, all held in direct ownership.
AEHR TEST SYSTEMS director Laura Oliphant reported multiple open-market sales of common stock. On January 22, 2026, she sold 3,100, 1,026, 180, 100, and 140 shares of AEHR common stock at prices ranging from $31.38 to $31.485 per share.
After these transactions, she beneficially owned 18,432 shares directly and 7,665 shares indirectly through a trust. The directly held amount includes shares subject to unvested restricted stock units.
A holder of common stock filed a notice of proposed sale under Rule 144, covering 4,546 shares to be sold through Fidelity Brokerage Services LLC on or about 01/22/2026 on the NASDAQ market. The filing lists an aggregate market value of 142,750.68 for these shares and notes that there are 30,627,342 shares of the same class outstanding.
The shares to be sold were acquired as restricted stock vesting compensation from the issuer in multiple tranches between 01/27/2024 and 01/11/2025, including vestings of 558, 557, 558, 1,158, 557, and 1,158 shares. The person on whose behalf the sale is being made represents that they are not aware of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Aehr Test Systems officer Alistair N. Sporck reported a tax-related share withholding on company stock. On 01/19/2026, 387 shares of common stock were withheld at a price of $28.81 per share to cover tax obligations upon the vesting of restricted stock units. The filing clarifies that this was not a sale by the reporting person, but a share withholding for taxes.
After this transaction, Sporck beneficially owned 28,305 shares of Aehr Test Systems common stock directly, which includes shares subject to unvested restricted stock units. In addition, the filing reports 5,214 shares held indirectly through a trust.
AEHR Test Systems executive Vernon Rogers reported a routine tax-related share withholding. On 01/14/2026, 464 shares of AEHR common stock were withheld at $25.97 per share to cover tax obligations that arose when restricted stock units vested. The company notes this withholding does not represent a sale by the executive.
After this transaction, Rogers beneficially owned 177,366 shares, which includes shares underlying unvested restricted stock units. The filing reflects the executive’s updated equity position rather than an open-market trade.
AEHR TEST SYSTEMS chief technology officer Donald P. Richmond II reported a routine tax-related share withholding. On 01/14/2026, 343 shares of common stock were withheld at a price of $25.97 per share to cover tax obligations triggered by the vesting of restricted stock units, and this was not an open-market sale. After this transaction, he beneficially owned 213,334 shares, which include shares subject to unvested restricted stock units, all held in direct ownership form.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
